1. Friedler S, Zimerman A, Schachter M, Raziel A, Strassburger D, Ron El R. The midluteal decline in serum estradiol levels is drastic but not deleterious for implantation after in vitro fertilization and embryo transfer in patients with normal or high responses. Fertil Steril 2005;83:54-60.
2. Mitwally MF, Bhakoo HS, Crickard K, Sullivan MW, Batt RE, Yeh J. Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer. Fertil Steril 2006;86:588-96.
3. Blazar AS, Hogan JW, Frankfurter D, Hackett R, Keefe DL. Serum estradiol positively predicts outcomes in patients undergoing in vitro fertilization. Fertil Steril 2004;81:1707-9.
4. Kosmas IP, Kolibianakis EM, Devroey P. Association of estradiol levels on the day of hCG administration and pregnancy achievement in IVF: a systematic review. Hum Reprod 2004;19:2446-53.
5. Costello MF, Emerson S, Lukic J, Sjoblom P, Garrett D, Hughes G, et al. Predictive value of mid luteal progesterone concentration before luteal support in controlled ovarian hyperstimulation with intrauterine insemination. Aust N Z J Obstet Gynaecol 2004;44:51-6.
6. Huang B, Ren X, Wu L, Zhu L, Xu B, Li Y, et al. Elevated progesterone levels on the day of oocyte maturation may affect top quality embryo IVF cycles. PLoS One 2016;11:0145895.
7. Kondapalli LA, Molinaro TA, Sammel MD, Dokras A. A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles. Hum Reprod 2012;27:2690-7.
8. Kyrou D, Popovic-Todorovic B, Fatemi HM, Bourgain C, Haentjens P, Van Landuyt L, et al. Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist? Hum Reprod 2009;24:2902-9.
9. Molinaro TA, Shaunik A, Lin K, Sammel MD, Barnhart KT. A strict infertility diagnosis has poor agreement with the clinical diagnosis entered into the Society for Assisted Reproductive Technology registry. Fertil Steril 2009;92:2088-90.
10. Makkar G, Ng EH, Yeung WS, Ho PC. Prognostic factors for successful outcome in patients undergoing controlled ovarian stimulation and intrauterine insemination. Hong Kong Med J 2003;9:341-5.
11. Friedler S, Schenker JG, Herman A, Lewin A. The role of ultrasonography in theevaluation of endometrial receptivity following assisted reproductive treatments: a critical review. Hum Reprod Update 1996;2:323-35.
12. Maegawa M, Kamada M, Takayanagi M, Naka O, Irahara M, Aono T. Difference of the hormonal profile at the periovulatory phase in pregnant and nonpregnant cycles of infertile women with unexplained etiology. Gynecol Obstet Invest 1993;35:228-31.
13. Gleicher N, Brown T, Dudkiewicz A, Karande V, Rao R, Balin M, et al. Estradiol/progesterone substitution in the luteal phase improves pregnancy rates in stimulated cycles--but only in younger women. Early Pregnancy 2000;4:64-73.
14. Thuesen LL, Andersen AN, Loft A, Smitz J. Intrafollicular endocrine milieu after addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization. J Clin Endocrinol Metab 2014;99:517-26.
15. Fatemi H, Van Vaerenbergh I. Significance of premature progesterone rise in IVF. Curr Opin Obstet Gynecol 2015;27:242-8.
16. Roque M, Valle M, Guimarães F, Sampaio M, Geber S. Freeze-all policy: fresh vs. frozen-thawed embryo transfer. Fertil Steril 2015;103:1190-3.
17. Liu L, Zhao L, Li TC, Zhu H, Lin X, Jin X, et al. Comparison of progesterone measurement on day of, and day after, HCG administration in IVF-embryo transfer cycles. Reprod Biomed Online 2015;30:157-65.
18. Papaleo E, Corti L, Vanni VS, Pagliardini L, Ottolina J, De Michele F, et al. Basal progesterone level as the main determinant of progesterone elevation on the day of progesterone elevation on the day of hCG triggering in controlled ovarian stimulation cycles. Arch Gynecol Obstet 2014;290:169-76.
19. Rehman R, Hussain Z, Zuberi NA. Prediction of success in intracytoplasmic sperm injection (ICSI) byestimation of serum estradiol/progesterone ratio on the day of embryo transfer. J Pak Med Assoc 2013;63:609-13.
20. Venetis CA, Kolibianakis EM, Bosdou JK, Tarlatzis BC. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum Reprod Update 2013;19:433-57.
21. Bosch E, Valencia I, Escudero E, Crespo J, Simon C, Remohi J, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril 2003;80:1444-9.
22. Al-Azemi M, Kyrou D, Kolibianakis EM, Humaidan P, Van Vaerenbergh I, Devroey P, et al. Elevated progesterone during ovarian stimulation for IVF. Reprod Biomed Online 2012;24:381-8.
23. Lee FK, Lai TH, Lin TK, Horng SG, Chen SC. Relationship of progesterone/estradiol ratio on day of hCG administration and pregnancy outcomes in high responders undergoing in vitro fertilization. Fertil Steril 2009;92:1284-9.
24. Lai TH, Lee FK, Lin TK, Horng SG, Chen SC, Chen YH, et al. An increased serum progesterone-to-estradiol ratio on the day of human chorionic gonadotropin administration does not have a negative impact on clinical pregnancy rate in women with normal ovarian reserve treated with a long gonadotropin releasing hormone agonist protocol. Fertil Steril 2009;92:508-14.
25. Younis JS, Haddad S, Matilsky M, Ben-Ami M. Premature luteinization: could it be an early manifestation of low ovarian reserve? Fertil Steril 1998;69:461-5.
26. Requena A, Cruz M, Bosch E, Meseguer M, Garcia-Velasco JA. High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study. Reprod Biol Endocrinol 2014;12:69.
27. Bourgain C, Ubaldi F, Tavaniotou A, Smitz J, Van Steirteghem AC, Devroey P. Endometrial hormone receptors and proliferation index in the periovulatory phase of stimulated embryo transfer cycles in comparison with natural cycles and relation to clinical pregnancy outcome. Fertil Steril 2002;78:237-44.
28. Elgindy EA, El-Haieg DO, Mostafa MI, Shafiek M. Does luteal estradiol supplementation have a role in long agonist cycles? Fertil Steril 2010;93:2182-8.
29. Wuttke W, Theiling K, Hinney B, Pitzel L. Regulation of steroid production and its function with in the corpus luteum. Steroids 1998;63:299-305.
30. Pabuccu R, Akar ME. Luteal phase support in assisted reproductive technology. Curr Opin Obstet Gynecol 2005;17:277-81.
31. Mun oz E, Taboas E, Portela S, Aguilar J, Fernandez I, Muñoz L, et al. Treatment of luteal phase defects in assisted reproduction. Curr DrugTargets 2013;14:832-42.
32. Zhang XM, Lv F, Wang P, Huang XM, Liu KF, Pan Y, et al. Estrogen supplementation to progesterone as luteal phase support in patients undergoing in vitro fertilization: systematic review and meta-analysis. Medicine (Baltimore) 2015;94:459.